Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms, Plasma Cell 1 Neoplasms 1 Influenza, Human 1

Interventions

Influenza Vaccines 7 Vaccines 2 SARS-CoV-2 inactivated vaccines 1 Lenalidomide 1 Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate 1 Fluzone High-Dose 1 FluMist 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Influenza, Human × Fluzone High-Dose × Clear all

NCT01666782 2016-06-24

IMMUNE

Rochester General Hospital

Phase 2 Completed

105 enrolled 10 charts

Influenza, Human, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡